New insights into angiopoietin-like proteins in lipid metabolism and cardiovascular disease risk

Current Opinion in Lipidology - Tập 30 Số 3 - Trang 205-211 - 2019
Sander Kersten1,2,3
1Nutrition, Metabolism and Genomics group, Division of Human Nutrition and Health, Wageningen University, Wageningen, the Netherlands
2e-mail: [email protected]
3to Sander Kersten, PhD, Nutrition, Metabolism and Genomics Group, Division of Human Nutrition and Health, Wageningen University, Stippeneng 4, 6708 WE Wageningen, The Netherlands. Tel: +31 317 485787

Tóm tắt

Purpose of review The angiopoietin-like proteins (ANGPTLs), consisting of ANGPTL3, ANGPTL4, and ANGPTL8, have gained significant interest for their role as inhibitors of lipoprotein lipase (LPL) and for their potential as therapeutic targets for correcting dyslipidemia. This review provides an overview of the most relevant new insights on the connection between ANGPTLs, plasma lipids, and coronary artery disease. Recent findings Carriers of loss-of-function variants in ANGPTL3 have a reduced risk of coronary artery disease and reduced plasma levels of triglycerides and LDL-C, while carriers of loss-of-function variants in ANGPTL4 have a reduced risk of coronary artery disease and reduced plasma levels of triglycerides and increased HDL-C. There is evidence that carrier status of ANGPTL4 loss-of-function variants may also influence risk of type 2 diabetes. ANGPTL3 is produced in liver and is released as a complex with ANGPTL8 to suppress LPL activity in fat and muscle tissue. ANGPTL4 is produced by numerous tissues and likely mainly functions as a locally released LPL inhibitor. Both proteins inactivate LPL by catalyzing the unfolding of the hydrolase domain in LPL and by promoting the cleavage of LPL. Antisense oligonucleotide and monoclonal antibody-based inactivation of ANGPTL3 reduce plasma triglyceride and LDL-C levels in human volunteers and suppress atherosclerosis in mouse models. Summary ANGPTL3/ANGPTL8 and ANGPTL4 together assure the appropriate distribution of plasma triglycerides across tissues during different physiological conditions. Large-scale genetic studies provide strong rationale for continued research efforts to pharmacologically inactivate ANGPTL3 and possibly ANGPTL4 to reduce plasma lipids and coronary artery disease risk.

Từ khóa


Tài liệu tham khảo

Kersten, 2014, Physiological regulation of lipoprotein lipase, Biochim Biophys Acta, 1841, 919, 10.1016/j.bbalip.2014.03.013

Zandbergen, 2006, Fasting-induced adipose factor/angiopoietin-like protein 4: a potential target for dyslipidemia, Fut Lipidol, 1, 227, 10.2217/17460875.1.2.227

Dijk, 2016, Regulation of lipid metabolism by angiopoietin-like proteins, Curr Opin Lipidol, 27, 249, 10.1097/MOL.0000000000000290

Musunuru, 2010, Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia, N Engl J Med, 363, 2220, 10.1056/NEJMoa1002926

Dewey, 2017, Genetic and pharmacologic inactivation of ANGPTL3 and cardiovascular disease, N Engl J Med, 377, 211, 10.1056/NEJMoa1612790

Helgadottir, 2016, Variants with large effects on blood lipids and the role of cholesterol and triglycerides in coronary disease, Nat Genet, 48, 634, 10.1038/ng.3561

Stitziel, 2017, ANGPTL3 deficiency and protection against coronary artery disease, J Am Coll Cardiol, 69, 2054, 10.1016/j.jacc.2017.02.030

Romeo, 2007, Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL, Nat Genet, 39, 513, 10.1038/ng1984

Mysling, 2016, The angiopoietin-like protein ANGPTL4 catalyzes unfolding of the hydrolase domain in lipoprotein lipase and the endothelial membrane protein GPIHBP1 counteracts this unfolding, eLife, 5, e20958, 10.7554/eLife.20958

Dewey, 2016, Inactivating variants in ANGPTL4 and risk of coronary artery disease, N Engl J Med, 374, 1123, 10.1056/NEJMoa1510926

Liu, 2017, Exome-wide association study of plasma lipids in >300,000 individuals, Nat Genet, 49, 1758, 10.1038/ng.3977

Stitziel, 2016, Coding variation in ANGPTL4, LPL, and SVEP1 and the risk of coronary disease, N Engl J Med, 374, 1134, 10.1056/NEJMoa1507652

Lotta, 2018, Association of genetically enhanced lipoprotein lipase-mediated lipolysis and low-density lipoprotein cholesterol-lowering alleles with risk of coronary disease and type 2 diabetes, JAMA Cardiol, 3, 957, 10.1001/jamacardio.2018.2866

Klarin, 2018, Genetics of blood lipids among ∼300,000 multiethnic participants of the Million Veteran Program, Nat Genet, 50, 1514, 10.1038/s41588-018-0222-9

Peloso, 2014, Association of low-frequency and rare coding-sequence variants with blood lipids and coronary heart disease in 56,000 whites and blacks, Am J Hum Genet, 94, 223, 10.1016/j.ajhg.2014.01.009

Gusarova, 2018, Genetic inactivation of ANGPTL4 improves glucose homeostasis and is associated with reduced risk of diabetes, Nat Commun, 9, 2252, 10.1038/s41467-018-04611-z

Dijk, 2016, Angiopoietin-like 4 promotes intracellular degradation of lipoprotein lipase in adipocytes, J Lipid Res, 57, 1670, 10.1194/jlr.M067363

Dijk, 2018, Angiopoietin-like 4 promotes the intracellular cleavage of lipoprotein lipase by PCSK3/furin in adipocytes, J Biol Chem, 293, 14134, 10.1074/jbc.RA118.002426

Cushing, 2017, Angiopoietin-like 4 directs uptake of dietary fat away from adipose during fasting, Mol Metab, 6, 809, 10.1016/j.molmet.2017.06.007

Kroupa, 2012, Linking nutritional regulation of Angptl4, Gpihbp1, and Lmf1 to lipoprotein lipase activity in rodent adipose tissue, BMC Physiol, 12, 13, 10.1186/1472-6793-12-13

Lichtenstein, 2007, Angptl4 upregulates cholesterol synthesis in liver via inhibition of LPL- and HL-dependent hepatic cholesterol uptake, Arterioscler, Thromb, Vasc Biol, 27, 2420, 10.1161/ATVBAHA.107.151894

Bergo, 2002, Down-regulation of adipose tissue lipoprotein lipase during fasting requires that a gene, separate from the lipase gene, is switched on, J Biol Chem, 277, 11927, 10.1074/jbc.M200325200

Doolittle, 1990, The response of lipoprotein lipase to feeding and fasting: evidence for posttranslational regulation, J Biol Chem, 265, 4570, 10.1016/S0021-9258(19)39601-2

Quagliarini, 2012, Atypical angiopoietin-like protein that regulates ANGPTL3, Proc Natl Acad Sci USA, 109, 19751, 10.1073/pnas.1217552109

Chi, 2017, ANGPTL8 promotes the ability of ANGPTL3 to bind and inhibit lipoprotein lipase, Mol Metab, 6, 1137, 10.1016/j.molmet.2017.06.014

Haller, 2017, ANGPTL8 requires ANGPTL3 to inhibit lipoprotein lipase and plasma triglyceride clearance, J Lipid Res, 58, 1166, 10.1194/jlr.M075689

Wang, 2015, Hepatic ANGPTL3 regulates adipose tissue energy homeostasis, Proc Natl Acad Sci USA, 112, 11630, 10.1073/pnas.1515374112

Catoire, 2014, Fatty acid-inducible ANGPTL4 governs lipid metabolic response to exercise, Proc Natl Acad Sci USA, 111, E1043, 10.1073/pnas.1400889111

Dijk, 2015, ANGPTL4 mediates shuttling of lipid fuel to brown adipose tissue during sustained cold exposure, eLife, 4, e08428, 10.7554/eLife.08428

Singh, 2018, Brown adipose tissue derived ANGPTL4 controls glucose and lipid metabolism and regulates thermogenesis, Mol Metab, 11, 59, 10.1016/j.molmet.2018.03.011

Lichtenstein, 2010, Angptl4 protects against severe proinflammatory effects of saturated fat by inhibiting fatty acid uptake into mesenteric lymph node macrophages, Cell Metab, 12, 580, 10.1016/j.cmet.2010.11.002

Janssen, 2018, Loss of angiopoietin-like 4 (ANGPTL4) in mice with diet-induced obesity uncouples visceral obesity from glucose intolerance partly via the gut microbiota, Diabetologia, 61, 1447, 10.1007/s00125-018-4583-5

Aryal, 2018, Absence of ANGPTL4 in adipose tissue improves glucose tolerance and attenuates atherogenesis, JCI Insight, 3, 97918, 10.1172/jci.insight.97918

Mandard, 2006, The fasting-induced adipose factor/angiopoietin-like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity, J Biol Chem, 281, 934, 10.1074/jbc.M506519200

Tikka, 2014, Silencing of ANGPTL 3 (angiopoietin-like protein 3) in human hepatocytes results in decreased expression of gluconeogenic genes and reduced triacylglycerol-rich VLDL secretion upon insulin stimulation, Biosci Rep, 34, e00160, 10.1042/BSR20140115

Gusarova, 2014, ANGPTL8/betatrophin does not control pancreatic beta cell expansion, Cell, 159, 691, 10.1016/j.cell.2014.09.027

Mattijssen, 2012, Regulation of triglyceride metabolism by angiopoietin-like proteins, Biochim Biophys Acta, 1821, 782, 10.1016/j.bbalip.2011.10.010

Sukonina, 2006, Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue, Proc Natl Acad Sci USA, 103, 17450, 10.1073/pnas.0604026103

Kovrov, 2019, On the mechanism of angiopoietin-like protein 8 for control of lipoprotein lipase activity, J Lipid Res, 10.1194/jlr.M088807

Kristensen, 2018, A disordered acidic domain in GPIHBP1 harboring a sulfated tyrosine regulates lipoprotein lipase, Proc Natl Acad Sci USA, 115, E6020, 10.1073/pnas.1806774115

Chi, 2015, Angiopoietin-like 4 modifies the interactions between lipoprotein lipase and its endothelial cell transporter GPIHBP1, J Biol Chem, 290, 11865, 10.1074/jbc.M114.623769

Liu, 2010, Angiopoietin-like protein 3 inhibits lipoprotein lipase activity through enhancing its cleavage by proprotein convertases, J Biol Chem, 285, 27561, 10.1074/jbc.M110.144279

Graham, 2017, Cardiovascular and metabolic effects of ANGPTL3 antisense oligonucleotides, N Engl J Med, 377, 222, 10.1056/NEJMoa1701329

Wang, 2015, Inactivation of ANGPTL3 reduces hepatic VLDL-triglyceride secretion, J Lipid Res, 56, 1296, 10.1194/jlr.M054882

Gaudet, 2017, ANGPTL3 inhibition in homozygous familial hypercholesterolemia, N Engl J Med, 377, 296, 10.1056/NEJMc1705994

Xu, 2018, Role of angiopoietin-like 3 (ANGPTL3) in regulating plasma level of low-density lipoprotein cholesterol, Atherosclerosis, 268, 196, 10.1016/j.atherosclerosis.2017.08.031

Oteng, 2017, Feeding Angptl4−/− mice trans-fat promotes foam cell formation in mesenteric lymph nodes without leading to ascites, J Lipid Res, 58, 1100, 10.1194/jlr.M074278

Aryal, 2016, ANGPTL4 deficiency in haematopoietic cells promotes monocyte expansion and atherosclerosis progression, Nat Commun, 7, 12313, 10.1038/ncomms12313

Dijk, 2018, Regulation of angiopoietin-like 4 and lipoprotein lipase in human adipose tissue, J Clin Lipidol, 12, 773, 10.1016/j.jacl.2018.02.006

Ren, 2012, Identification of RIFL, a novel adipocyte-enriched insulin target gene with a role in lipid metabolism, Am J Physiol Endocrinol Metab, 303, E334, 10.1152/ajpendo.00084.2012